Anti-angiogenesis: disappointment in localised oesophagogastric cancer

Trevor Leong, B Mark Smithers, Michael Michael, Val Gebski, Alex Boussioutas, Danielle Miller, John Simes, John Zalcberg, Karin Haustermans, Florian Lordick, Christoph Schuhmacher, Carol Swallow, Gail Darling, Rebecca Wong, TOPGEAR : a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG) BMC Cancer. ,vol. 15, pp. 532- 532 ,(2015) , 10.1186/S12885-015-1529-X

A.F.C. Okines, R.E. Langley, L.C. Thompson, S.P. Stenning, L. Stevenson, S. Falk, M. Seymour, F. Coxon, G.W. Middleton, D. Smith, L. Evans, S. Slater, J. Waters, D. Ford, M. Hall, T.J. Iveson, R.D. Petty, C. Plummer, W.H. Allum, J.M. Blazeby, M. Griffin, D. Cunningham, Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety report Annals of Oncology. ,vol. 24, pp. 702- 709 ,(2013) , 10.1093/ANNONC/MDS533

David Cunningham, William H Allum, Sally P Stenning, Jeremy N Thompson, Cornelis JH Van de Velde, Marianne Nicolson, J Howard Scarffe, Fiona J Lofts, Stephen J Falk, Timothy J Iveson, David B Smith, Ruth E Langley, Monica Verma, Simon Weeden, YKS Viswanath Chua, Yu Jo, MAGIC Trial participants, Nick Wadd, None, Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer The New England Journal of Medicine. ,vol. 355, pp. 11- 20 ,(2006) , 10.1056/NEJMOA055531

Adam J Bass, Vesteinn Thorsson, Ilya Shmulevich, Sheila M Reynolds, Michael Miller, Brady Bernard, Toshinori Hinoue, Peter W Laird, Christina Curtis, Hui Shen, Daniel J Weisenberger, Nikolaus Schultz, Ronglai Shen, Nils Weinhold, David P Kelsen, Reanne Bowlby, Andy Chu, Katayoon Kasaian, Andrew J Mungall, A Gordon Robertson, Payal Sipahimalani, Andrew Cherniack, Gad Getz, Yingchun Liu, Michael S Noble, Chandra Pedamallu, Carrie Sougnez, Amaro Taylor-Weiner, Rehan Akbani, Ju-Seog Lee, Wenbin Liu, Gordon B Mills, Da Yang, Wei Zhang, Angeliki Pantazi, Michael Parfenov, Margaret Gulley, M Blanca Piazuelo, Barbara G Schneider, Jihun Kim, Alex Boussioutas, Margi Sheth, John A Demchok, Charles S Rabkin, Joseph E Willis, Sam Ng, Katherine Garman, David G Beer, Arjun Pennathur, Benjamin J Raphael, Hsin-Ta Wu, Robert Odze, Hark K Kim, Jay Bowen, Kristen M Leraas, Tara M Lichtenberg, Stephanie Weaver, Michael McLellan, Maciej Wiznerowicz, Ryo Sakai, Michael S Lawrence, Kristian Cibulskis, Lee Lichtenstein, Sheila Fisher, Stacey B Gabriel, Eric S Lander, Li Ding, Beifang Niu, Adrian Ally, Miruna Balasundaram, Inanc Birol, Denise Brooks, Yaron SN Butterfield, Rebecca Carlsen, Justin Chu, Eric Chuah, Hye-Jung E Chun, Amanda Clarke, Noreen Dhalla, Ranabir Guin, Robert A Holt, None, Comprehensive molecular characterization of gastric adenocarcinoma Nature. ,vol. 513, pp. 202- 209 ,(2014) , 10.1038/NATURE13480

Atsushi Ohtsu, Manish A. Shah, Eric Van Cutsem, Sun Young Rha, Akira Sawaki, Sook Ryun Park, Ho Yeong Lim, Yasuhide Yamada, Jian Wu, Bernd Langer, Michal Starnawski, Yoon-Koo Kang, Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study Journal of Clinical Oncology. ,vol. 29, pp. 3968- 3976 ,(2011) , 10.1200/JCO.2011.36.2236

Florian Lordick, Yelena Y. Janjigian, Clinical impact of tumour biology in the management of gastroesophageal cancer Nature Reviews Clinical Oncology. ,vol. 13, pp. 348- 360 ,(2016) , 10.1038/NRCLINONC.2016.15

Radka Obermannová, Florian Lordick, Insights into next developments in advanced gastric cancer Current Opinion in Oncology. ,vol. 28, pp. 367- 375 ,(2016) , 10.1097/CCO.0000000000000289

Elizabeth C Smyth, Matteo Fassan, David Cunningham, William H Allum, Alicia FC Okines, Andrea Lampis, Jens C Hahne, Massimo Rugge, Clare Peckitt, Matthew Nankivell, Ruth Langley, Michele Ghidini, Chiara Braconi, Andrew Wotherspoon, Heike I Grabsch, Nicola Valeri, None, Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial Journal of Clinical Oncology. ,vol. 34, pp. 2721- 2727 ,(2016) , 10.1200/JCO.2015.65.7692

Salah-Eddin Al-Batran, Ralf D Hofheinz, Claudia Pauligk, Hans-Georg Kopp, Georg Martin Haag, Kim Barbara Luley, Johannes Meiler, Nils Homann, Sylvie Lorenzen, Harald Schmalenberg, Stephan Probst, Michael Koenigsmann, Matthias Egger, Nicole Prasnikar, Karel Caca, Jörg Trojan, Uwe M Martens, Andreas Block, Wolfgang Fischbach, Rolf Mahlberg, Michael Clemens, Gerald Illerhaus, Katja Zirlik, Dirk M Behringer, Wolff Schmiegel, Michael Pohl, Michael Heike, Ulrich Ronellenfitsch, Martin Schuler, Wolf O Bechstein, Alfred Königsrainer, Timo Gaiser, Peter Schirmacher, Wael Hozaeel, Alexander Reichart, Thorsten O Goetze, Mark Sievert, Elke Jäger, Stefan Mönig, Andrea Tannapfel, Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial The Lancet Oncology. ,vol. 17, pp. 1697- 1708 ,(2016) , 10.1016/S1470-2045(16)30531-9

David Cunningham, Sally P Stenning, Elizabeth C Smyth, Alicia F Okines, William H Allum, Sam Rowley, Laura Stevenson, Heike I Grabsch, Derek Alderson, Thomas Crosby, S Michael Griffin, Wasat Mansoor, Fareeda Y Coxon, Stephen J Falk, Suzanne Darby, Kate A Sumpter, Jane M Blazeby, Ruth E Langley, Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial The Lancet Oncology. ,vol. 18, pp. 357- 370 ,(2017) , 10.1016/S1470-2045(17)30043-8